A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.
- Published In:
- British journal of haematology, 178(3), 413-426 (2017)
- Authors:
- Lu, Chenyang, Meng, Shan, Jin, Yanxia, Zhang, Wanggang, Li, Zongfang, Wang, Fang, Wang-Johanning, Feng, Wei, Yongchang, Liu, Hailing, Tu, Honglei, Su, Dan, He, Aili, Cao, Xingmei, Zhou, Fuling
- Database ID:
- RPEP-03378
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03378APA
Lu, Chenyang; Meng, Shan; Jin, Yanxia; Zhang, Wanggang; Li, Zongfang; Wang, Fang; Wang-Johanning, Feng; Wei, Yongchang; Liu, Hailing; Tu, Honglei; Su, Dan; He, Aili; Cao, Xingmei; Zhou, Fuling. (2017). A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.. British journal of haematology, 178(3), 413-426. https://doi.org/10.1111/bjh.14686
MLA
Lu, Chenyang, et al. "A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.." British journal of haematology, 2017. https://doi.org/10.1111/bjh.14686
RethinkPeptides
RethinkPeptides Research Database. "A novel multi-epitope vaccine from MMSA-1 and DKK1 for multi..." RPEP-03378. Retrieved from https://rethinkpeptides.com/research/lu-2017-a-novel-multiepitope-vaccine
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.